Dietary SCFAs Immunotherapy: Reshaping the Gut Microbiota in Diabetes
There is evidence to suggest the strong influence of diet and gut microbiota in the development of inflammatory diseases such as autoimmune T1D, obesity, and T2D. In synergy with each individual's genetics & lifestyle, the gut microbiota is sophisticatedly designed to fight against diseases. Simple alterations in the intestinal microbiota, such as robustly increasing the abundance of SCFA producers and thereby boosting SCFA concentrations by specialised medicinal diets, may represent a novel and attractive therapeutic approach for the prevention and treatment of Diabetes.
MAT-IN-2203012 V1.0 11/22